Ketamine is a dissociative anaesthetic that has been used in the clinic for many years. At low, subanaesthetic doses, it is a relatively selective and potent antagonist of the N-methyl-D-aspartate (NMDA) receptor. It belongs to the class of uncompetitive antagonists and blocks the receptor by binding to a specific site within the NMDA receptor channel when it is open. Like other compounds of this class, ketamine can cause hallucinations or other untoward central effects which limit its use in the clinic. Nevertheless, because of the evidence on the importance of NMDA receptor-mediated pLasticity in chronic pain, low doses of ketamine have been explored in a wide range of pain conditions. The majority of studies with ketamine have shown efficacy; however, it has not been possible to separate safely the pain relief from the side effects of the drug. Hence, clinical use of ketamine as a pain treatment is very limited. Nevertheless, ketamine has served as a useful tool to provide a compelling rationale for developing other NMDA antagonists. Some of the new compounds of this class, particularly those acting at the NR2B subtype of the NMDA receptor, have shown promise in preclinical and clinical studies.
Aida S. , Yamakura T. , Baba H. , Taga K. , Fukuda S. , Shimoji K. (2000) Preemptive analgesia by intravenous low-dose ketamine and epidural morphine in gastrectomy: a randomized double-blind study . Anesthesiology92: 1624—1630
2.
Andersen O.K. , Felsby S. , Nicolaisen L. , Bjerring P. , Jensen T.S. , Arendt-Nielsen L. (1996) The effect of ketamine on stimulation of primary and secondary hyperalgesic areas induced by capsaicin — a double-blind, placebo-controlled, human experimental study . Pain66: 51—62
3.
Anis N.A. , Berry S.C. , Burton N.R. , Lodge D. (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate . Br J Pharmacol79: 565—575
4.
Arendt-Nielsen L. , Petersen-Felix S. (1995) Wind-up and neuroplasticity: is there a correlation to clinical pain?Eur J Anaesthesiol Suppl10: 1—7
5.
Arendt-Nielsen L. , Petersen-Felix S. , Fischer M. , Bak P. , Bjerring P. , Zbinden A.M. (1995) The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study . Anesth Analg81: 63—68
6.
Attal N. , Bouhassira D. (1999) Mechanisms of pain in peripheral neuropathy . Acta Neurol Scand Suppl173: 12—24
7.
Baba H. , Ji R.R. , Kohno T. , Moore K.A. , Ataka T. , Wakai A. , Okamoto M. , Woolf C.J. (2003) Removal of GABAergic inhibition facilitates polysynaptic A fiber-mediated excitatory transmission to the superficial spinal dorsal horn . Mol Cell Neurosci24: 818—830
8.
Banic B. , Petersen-Felix S. , Andersen O.K. , Radanov B.P. , Villiger P.M. , Arendt-Nielsen L. , Curatolo M. (2004) Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia . Pain107: 7—15
9.
Baumeister A. , Advokat C. (1991) Evidence for a supraspinal mechanism in the opioid-mediated antinociceptive effect of ketamine . Brain Res566: 351—353
10.
Blackburn-Munro G. (2004) Pain-like behaviours in animals — how human are they?Trends Pharmacol Sci25: 299—305
11.
Brennan T.J. , Zahn P.K. , Pogatzki-Zahn E.M. (2005) Mechanisms of incisional pain . Anesthesiol Clin North America23: 1—20
12.
Burstein R. (2001) Deconstructing migraine headache into peripheral and central sensitization . Pain89: 107—110
13.
Burton A.W. , Lee D.H. , Saab C. , Chung J.M. (1999) Preemptive intrathecal ketamine injection produces a long-lasting decrease in neuropathic pain behaviors in a rat model . Reg Anesth Pain Med24: 208—213
Chang L. (1998) The association of functional gastrointestinal disorders and fibromyalgia . Eur J Surg Suppl: 32—36
16.
Chang L. , Mayer E.A. , Johnson T. , FitzGerald L.Z. , Naliboff B. (2000) Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia . Pain84: 297—307
17.
Chen H.S. , Pellegrini J.W. , Aggarwal S.K. , Lei S.Z. , Warach S. , Jensen F.E. , Lipton S.A. (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity . J Neurosci12: 4427—4436
18.
Chizh B.A. (2002) Novel approaches to targeting glutamate receptors for the treatment of chronic pain: review article . Amino Acids23: 169—176
19.
Chizh B.A. , Cumberbatch M.J. , Herrero J.F. , Stirk G.C. , Headley P.M. (1997) Stimulus intensity, cell excitation and the N-methyl-D-aspartate receptor component of sensory responses in the rat spinal cord in vivo . Neuroscience80: 251—265
20.
Chizh B.A. , Scheede M. , Schlutz H. (2000) Antinociception and (R,S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid antagonism by gabapentin in the rat spinal cord in vivo . Naunyn Schmiedebergs Arch Pharmacol362: 197—200
21.
Chizh B.A. , Headley P.M. , Tzschentke T.M. (2001a) NMDA receptor antagonists as analgesics: focus on the NR2B subtype . Trends Pharmacol Sci22: 636—642
22.
Chizh B.A. , Englberger W. , Parsons C.G. , Christoph T. (2001b) The antiallodynic effect of N-methyl-D-aspartate (NMDA) antagonists in neuropathic pain outlasts the block of NMDA receptors . Soc Neurosci Abstr27: 53.14
23.
Chizh B.A. , Reissmuller E. , Schlutz H. , Scheede M. , Haase G. , Englberger W. (2001c) Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil . Neuropharmacology40: 212—220
24.
Chizh B.A. , Eide P.K. (2002) Pain. In L odge D , Danysz W , Parsons C G (eds), Therapeutic Potential of Ionotropic Glutamate Receptor Antagonists and Modulators, F.P. Graham Publishing Co., Johnson City, TN , pp 263—300.
25.
Chizh B.A. , Headley P.M. (2005) NMDA antagonists and neuropathic pain — multiple drug targets and multiple uses . Curr Pharm Des11: 2977—2994
26.
Chizh B.A. , Wang J. , O'Donnel M. , Sansbury F.H. , Quartey G. , Cookson L.M. (2005) Antihyperalgesic profiles of rofecoxib and ketamine in a new healthy volunteer model of inflammatory pain . IASP 11th World Congress on Pain, Abstracts: ID# 1222-P92
27.
Christoph T. , Reissmuller E. , Schiene K. , Englberger W. , Chizh B.A. (2005) Antiallodynic effects of NMDA glycineB antagonists in neuropathic pain: possible peripheral mechanisms . Brain Research1048: 218—227
28.
Coderre T.J. , Katz J. , Vaccarino A.L. , Melzack R. (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence . Pain52: 259—285
29.
Coffin B. , Sabat J. , Jian R. , Besson J. , Bouhassira D. (2002) Mechanisms of visceral pain in patients with inflammatory bowel disease or irritable bowel syndrome . 10th World Congress on Pain, August 2002, SanDiego, IASP Abstracts:1591-P139.
30.
Collingridge G.L. , Bliss T.V. (1995) Memories of NMDA receptors and LTP . Trends Neurosci18: 54—56
31.
Correll G.E. , Maleki J. , Gracely E.J. , Muir J.J. , Harbut R.E. (2004) Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome . Pain Med5: 263—275
32.
Cull-Candy S. , Brickley S. , Farrant M. (2001) NMDA receptor subunits: diversity, development and disease . Curr Opin Neurobiol11: 327—335
33.
Cumberbatch M.J. , Chizh B.A. , Headley P.M. (1994) AMPA receptors have an equal role in spinal nociceptive and non-nociceptive transmission . Neuroreport5: 877—880
34.
Cumberbatch M.J. , Chizh B.A. , Headley P.M. (2002) Spinal nociceptive processing: NMDA receptors and modulation by neuropeptides. In Sirinathsinghji D , Hill RG (eds), NMDA Antagonists as Potential Analgesic Drugs. Birkhäuser Verlag , Basel .
35.
Danysz W. , Parsons C.G. , Bresink I. , Quack G. (1995) Glutamate in CNS disorders . Drug News Perspect8: 261—277
36.
Davidson E.M. , Carlton S.M. (1998) Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors . Brain Res785: 136—142
37.
De Biasi S. , Rustioni A. (1988) Glutamate and substance p coexist in primary afferent terminals in the superficial laminae of spinal cord . PNAS85: 7820—7824
38.
Desmeules J.A. , Cedraschi C. , Rapiti E. , Baumgartner E. , Finckh A. , Cohen P. , Dayer P. , Vischer T.L. (2003) Neurophysiologic evidence for a central sensitization in patients with fibromyalgia . Arthritis Rheum48: 1420—1429
39.
Dickenson A.H. (1990) A cure for wind up: NMDA receptor antagonists as potential analgesics . Trends Pharmacol Sci11: 307—309
40.
Domino E.F. , Chodoff P. , Corssen G. (1965) Pharmacologic effects of CI-581, a new dissociative anesthetic, in man . Clin Pharmacol Ther40: 279—291
41.
Du J. , Zhou S. , Coggeshall R.E. , Carlton S.M. (2003) N-methyl-D-aspartate-induced excitation and sensitization of normal and inflamed nociceptors . Neuroscience118: 547—562
42.
Duggan A.W. , Furmidge L.J. (1994) Probing the brain and spinal cord with neuropeptides in pathways related to pain and other functions . Front Neuroendocrinol15: 275—300
43.
Eaton M. (2003) Common animal models for spasticity and pain . J Rehabil Res Dev40: 41—54
44.
Eide K. , Stubhaug A. , Oye I. , Breivik H. (1995) Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia . Pain61: 221—228
45.
Eide P.K. , Stubhaug A. , Breivik H. , Oye I. ( 1997) Reply to S.T. Meller: Ketamine: relief from chronic pain through actions at the NMDA receptor . Pain72: 289—291
46.
Eide P.K. (2000) Wind-up and the NMDA receptor complex from a clinical perspective . Eur J Pain4: 5—15
47.
Eisenberg E. , Pud D. ( 1998) Can patients with chronic neuropathic pain be cured by acute administration of the NMDA receptor antagonist amantadine?Pain74: 337—339
48.
Elia N. , Tramer M.R. (2005) Ketamine and postoperative pain — a quantitative systematic review of randomised trials . Pain113: 61—70
49.
Evans R.H. , Francis A.A. , Watkins J.C. (1977) Selective antagonism by Mg2+ of amino acid-induced depolarization of spinal neurones . Experientia33: 489—491
50.
Farrell M. , Gibson S. , McMeeken J. , Helme R. (2000) Pain and hyperalgesia in osteoarthritis of the hands . J Rheumatol27: 441—447
51.
Felsby S. , Nielsen J. , Arendt-Nielsen L. , Jensen T.S. (1996) NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride . Pain64: 283—291
52.
Fu E.S. , Miguel R. , Scharf J.E. (1997) Preemptive ketamine decreases postoperative narcotic requirements in patients undergoing abdominal surgery . Anesth Analg84: 1086—1090
53.
Gammaitoni A. , Gallagher R.M. , Welz-Bosna M. (2000) Topical ketamine gel: possible role in treating neuropathic pain . Pain Med1: 97—100
54.
Gibson S.J. , Granges G. , Littlejohn G.O. , Helme R.D. (1995) Increased thermal pain sensitivity in patients with fibromyalgia syndrome. In Bromm B , Desmedt J E (eds), Pain and the Brain: From Nociception to Cognition, Raven Press Ltd, New York , pp. 401—411
55.
Giesecke T. , Gracely R.H. , Grant M.A. , Nachemson A. , Petzke F. , Williams D.A. , Clauw D.J. (2004) Evidence of augmented central pain processing in idiopathic chronic low back pain . Arthritis Rheum50: 613—623
56.
Gilron I. , Quirion R. , Coderre T.J. (1999) Pre- versus postformalin effects of ketamine or large-dose alfentanil in the rat: discordance between pain behavior and spinal Fos-like immunoreactivity . Anesth Analg89: 128—135
57.
Gottrup H. , Bach F.W. , Arendt-Nielsen L. , Jensen T.S. (2000a) Peripheral lidocaine but not ketamine inhibits capsaicin-induced hyperalgesia in humans . Br J Anaesth85: 520—528
58.
Gottrup H. , Hansen P.O. , Arendt-Nielsen L. , Jensen T.S. (2000b) Differential effects of systemically administered ketamine and lidocaine on dynamic and static hyperalgesia induced by intradermal capsaicin in humans . Br J Anaesth84: 155—162
59.
Granot M. , Buskila D. , Granovsky Y. , Sprecher E. , Neumann L. , Yarnitsky D. (2001) Simultaneous recording of late and ultra-late pain evoked potentials in fibromyalgia. ClinicalNeurophysiology112: 1881—1887
60.
Graven-Nielsen T. , Aspegren K.S. , Henriksson K.G. , Bengtsson M. , Sorensen J. , Johnson A. , Gerdle B. , Arendt-Nielsen L. (2000) Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients . Pain85: 483—491
61.
Graven-Nielsen T. , Arendt-Nielsen L. (2002) Peripheral and central sensitization in musculoskeletal pain disorders: an experimental approach . Curr Rheumatol Rep4: 313—321
62.
Grimwood S. , Le Bourdelles B. , Atack J.R. , Barton C. , Cockett W. , Cook S.M. , Gilbert E. , Hutson P.H. , McKernan R.M. , Myers J. , Ragan C.I. , Wingrove P.B. , Whiting P.J. (1996) Generation and characterisation of stable cell lines expressing recombinant human N-methyl-D-aspartate receptor subtypes . J Neurochem66: 2239—2247
63.
Gurnani A. , Sharma P.K. , Rautela R.S. , Bhattacharya A. (1996) Analgesia for acute musculoskeletal trauma: low-dose subcutaneous infusion of ketamine . Anaesth Intensive Care24: 32—36
64.
Hansson P. (2003) Difficulties in stratifying neuropathic pain by mechanisms . Eur J Pain7: 353—357
65.
Herrero J.F. , Headley P.M. , Parsons C.G. (1994) Memantine selectively depresses NMDA receptor-mediated responses of rat spinal neurones in vivo . Neuroscience Letters165: 37—40
66.
Herrero J.F. , Laird J.M. , Lopez-Garcia J.A. (2000) Wind-up of spinal cord neurones and pain sensation: much ado about something ? Prog Neurobiol61: 169—203
67.
Hocking G. , Cousins M.J. (2003) Ketamine in chronic pain management: an evidence-based review . Anesth Analg97: 1730—1739
68.
Hughes A.M. , Rhodes J. , Fisher G. , Sellers M. , Growcott J.W. (2002) Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers . Br J Clin Pharmacol53: 604—612
69.
Jang J.H. , Kim D.W. , Sang N.T. , Se P.K. , Leem JW ( 2004) Peripheral glutamate receptors contribute to mechanical hyperalgesia in a neuropathic pain model of the rat . Neuroscience128: 169—176
70.
Jeftinija S. , Jeftinija K. , Liu F. , Skilling S.R. , Smullin D.H. , Larson A.A. (1991a) Excitatory amino acids are released from rat primary afferent neurons in vitro . Neurosci Lett125: 191—194
71.
Jeftinija S. , Jeftinija K. , Liu F. , Skilling S.R. , Smullin D.H. , Larson A.A. (1991b) Excitatory amino acids are released from rat primary afferent neurons in vitro . Neurosci Lett125: 191—194
72.
Jensen T.S. , Baron R. (2003) Translation of symptoms and signs into mechanisms in neuropathic pain . Pain102: 1—8
73.
Ji R.R. , Kohno T. , Moore K.A. , Woolf C.J. (2003) Central sensitization and LTP: do pain and memory share similar mechanisms?Trends Neurosci26: 696—705
74.
Jones M.W. , McClean M. , Parsons C.G. , Headley P.M. (2001) The in vivo relevance of the varied channel-blocking properties of uncompetitive NMDA antagonists: tests on spinal neurones . Neuropharmacology41: 50—61
75.
Kangrga I. , Randic M. (1991) Outflow of endogenous aspartate and glutamate from the rat spinal dorsal horn in vitro by activation of low- and high-threshold primary afferent fibers. Modulation by mu-opioids . Brain Res553: 347—352
76.
Kapur S. , Seeman P. (2002) NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia . Mol Psychiatry7: 837—844
77.
Kegeles L.S. , Martinez D. , Kochan L.D. , Hwang D.R. , Huang Y. , Mawlawi O. , Suckow R.F. , Van Heertum R.L. , Laruelle M. (2002) NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans . Synapse43: 19—29
78.
King A.E. , Lopez-Garcia J.A. (1993) Excitatory amino acid receptor-mediated neurotransmission from cutaneous afferents in rat dorsal horn in vitro . J Physiol472: 443—457
79.
Kirby L.C. , The Memantine Study Group (2002) Memantine in the treatment of diabetics with painful peripheral neuropathy: a placebo-controlled phase IIb trial . Pain Med3: 182
80.
Klein T. , Magerl W. , Hopf H.C. , Sandkuhler J. , Treede R.D. (2004) Perceptual correlates of nociceptive long-term potentiation and long-term depression in humans . J Neurosci24: 964—971
81.
Klein T. , Magerl W. , Rolke R. , Treede R.D. (2005) Human surrogate models of neuropathic pain . Pain115: 227—233
82.
Koppert W. , Zeck S. , Blunk J.A. , Schmelz M. , Likar R. , Sittl R. (1999) The effects of intradermal fentanyl and ketamine on capsaicin-induced secondary hyperalgesia and flare reaction . Anesth Analg89: 1521—1527
83.
Koppert W. , Dern S.K. , Sittl R. , Albrecht S. , Schuttler J. , Schmelz M. (2001) A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine . Anesthesiology95: 395—402
84.
Kornhuber J. , Mack-Burkhardt F. , Kornhuber M.E. , Riederer P. (1989) [3H]MK-801 binding sites in post-mortem human frontal cortex . Eur J Pharmacol162: 483—490
85.
Kornhuber J. , Bormann J. , Hubers M. , Rusche K. , Riederer P. (1991) Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study . Eur J Pharmacol206: 297—300
86.
Kronenberg R.H. (2002) Ketamine as an analgesic: parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration . J Pain Palliat Care Pharmacother16: 27—35
87.
Krystal J.H. , D'Souza D.C. (2001) Comment on `ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor' . Biological Psychiatry50: 555
88.
Laird J.M. , de la Rubia P.G. , Cervero F. (1995) Excitability changes of somatic and viscero-somatic nociceptive reflexes in the decerebratespinal rabbit: role of NMDA receptors . J Physiol489: 545—555
Leem J.W. , Hwang J.H. , Hwang S.J. , Park H. , Kim M.K. , Choi Y. ( 2001) The role of peripheral N-methyl-D-aspartate receptors in Freund's complete adjuvant induced mechanical hyperalgesia in rats . Neurosci Lett297: 155—158
91.
Lehmann K.A. , Klaschik M. (2001) Lack of pre-emptive analgesic effect of low-dose ketamine in postoperative patients: a prospective, randomised double-blind study . Schmerz15: 248—253
92.
Leung A. , Wallace M.S. , Ridgeway B. , Yaksh T. (2001) Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain . Pain91: 177—187
93.
Li J. , Simone D.A. , Larson A.A. (1999) Windup leads to characteristics of central sensitization . Pain79: 75—82
94.
Lodge D. , Anis N.A. , Burton N.R. (1982) Effects of optical isomers of ketamine on excitation of cat and rat spinal neurones by amino acids and acetylcholine . Neurosci Lett29: 281—286
95.
Low S.J. , Roland C.L. (2004) Review of NMDA antagonist-induced neurotoxicity and implications for clinical development . Int J Clin Pharmacol Ther42: 1—14
96.
Lubrano E. , Iovino P. , Tremolaterra F. , Parsons W.J. , Ciacci C. , Mazzacca G. (2001) Fibromyalgia in patients with irritable bowel syndrome. An association with the severity of the intestinal disorder . Int J Colorectal Dis16: 211—215
97.
MacDonald J.F. , Miljkovic Z. , Pennefather P. (1987) Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine . J Neurophysiol58: 251—266
98.
MacDonald J.F. , Bartlett M.C. , Mody I. , Pahapill P. , Reynolds J.N. , Salter M.W. , Schneiderman J.H. , Pennefather P.S. (1991) Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones . J Physiol432: 483—508
99.
McCartney C.J. , Sinha A. , Katz J. ( 2004) A qualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia . Anesth Analg98: 1385—400 , Table
100.
McRoberts J.A. , Coutinho S.V. , Marvizon J.C. , Grady E.F. , Tognetto M. , Sengupta J.N. , Ennes H.S. , Chaban V.V. , Amadesi S. , Creminon C. , Lanthorn T. , Geppetti P. , Bunnett N.W. , Mayer E.A. (2001) Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats . Gastroenterology120: 1737—1748
101.
Magerl W. , Klein T. , Hanschmann A. , Althaus M. , Treede R.D. (2005) The moderate affinity antagonist neramexane is a potent analgesic in a human surrogate model of neuropathic pain. IASP
102.
Maier C. , Dertwinkel R. , Mansourian N. , Hosbach I. , Schwenkreis P. , Senne I. , Skipka G. , Zenz M. , Tegenthoff M. (2003) Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain — results of a randomized double-blinded, placebo-controlled trial . Pain103: 277—283
103.
Mathisen L.C. , Aasbo V. , Raeder J. (1999) Lack of pre-emptive analgesic effect of (R)-ketamine in laparoscopic cholecystectomy . Acta Anaesthesiol Scand43: 220—224
104.
Maurset A. , Skoglund L.A. , Hustveit O. , Oye I. ( 1989) Comparison of ketamine and pethidine in experimental and postoperative pain . Pain36: 37—41
105.
Max M.B. , Byas-Smith M.G. , Gracely R.H. , Bennett G.J. (1995) Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo . Clin Neuropharmacol18: 360—368
106.
Mendell L.M. (1966) Physiological properties of unmyelinated fiber projection to the spinal cord . Exp Neurol16: 316—332
107.
Merighi A. , Polak J.M. , Theodosis D.T. (1991) Ultrastructural visualization of glutamate and aspartate immunoreactivities in the rat dorsal horn, with special reference to the co-localization of glutamate, substance P and calcitonin-gene related peptide . Neuroscience40: 67—80
108.
Mikkelsen S. , Ilkjaer S. , Brennum J. , Borgbjerg F.M. , Dahl J.B. (1999) The effect of naloxone on ketamine-induced effects on hyperalgesia and ketamine-induced side effects in humans . Anesthesiology90: 1539—1545
109.
Moore K.A. , Kohno T. , Karchewski L.A. , Scholz J. , Baba H. , Woolf C.J. (2002) Partial peripheral nerve injury promotes a selective loss of GABAergic Inhibition in the superficial dorsal horn of the spinal cord . J Neurosci22: 6724—6731
110.
Morris V.H. , Cruwys S.C. , Kidd B.L. (1997) Characterisation of capsaicin-induced mechanical hyperalgesia as a marker for altered nociceptive processing in patients with rheumatoid arthritis . Pain71: 179—186
111.
Morris V. , Cruwys S. , Kidd B. ( 1998) Increased capsaicin-induced secondary hyperalgesia as a marker of abnormal sensory activity in patients with fibromyalgia . Neurosci Lett250: 205—207
112.
Murray F. , Kennedy J. , Hutson P.H. , Elliot J. , Huscroft I. , Mohnen K. , Russell M.G. , Grimwood S. (2000) Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro . Eur J Pharmacol397: 263—270
113.
Nikolajsen L. , Gottrup H. , Kristensen A.G. , Jensen T.S. (2000) Memantine (a N-methyl-D-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study . Anesth Analg91: 960—966
114.
Nishimura M. , Sato K. , Okada T. , Yoshiya I. , Schloss P. , Shimada S. , Tohyama M. (1998) Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells . Anesthesiology88: 768—774
115.
Nowak L. , Bregestovski P. , Ascher P. , Herbet A. , Prochiantz A. (1984) Magnesium gates glutamate-activated channels in mouse central neurones . Nature307: 462—465
116.
Ochoa J. , Torebjork H.E. , Culp W.J. , Schady W. (1982) Abnormal spontaneous activity in single sensory nerve fibers in humans . Muscle Nerve5: S74-S77
117.
Olivar T. , Laird J.M. (1999) Differential effects of N-methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes . Pain79: 67—73
118.
Park K.M. , Max M.B. , Robinovitz E. , Gracely R.H. , Bennett G.J. (1995) Effects of intravenous ketamine, alfentanil, or placebo on pain, pin-prick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects . Pain63: 163—172
119.
Parsons C.G. , Gruner R. , Rozental J. , Millar J. , Lodge D. (1993) Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan) . Neuropharmacology32: 1337—1350
120.
Parsons C.G. , Danysz W. , Quack G. (1998) Glutamate in CNS disorders as a target for drug development — an update . Drug News Perspect11: 523—569
121.
Parsons C.G. , Gibbens H. , Magnago T.S. , Headley P.M. (1988) At which `sigma' site are the spinal actions of ketamine mediated?Neurosci Lett85: 322—328
122.
Parsons C.G. , Danysz W. , Quack G. (1999) Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist—a review of preclinical data . Neuropharmacology38: 735—767
123.
Petersen K.L. , Fields H.L. , Brennum J. , Sandroni P. , Rowbotham M.C. (2000) Capsaicin evoked pain and allodynia in post-herpetic neuralgia . Pain88: 125—133
124.
Pockett S. (1995) Long-term potentiation and depression in the intermediate gray matter of rat spinal cord in vitro . Neuroscience67: 791—798
125.
Pogatzki E.M. , Zahn P.K. , Brennan T.J. (2000) Effect of pretreatment with intrathecal excitatory amino acid receptor antagonists on the development of pain behavior caused by plantar incision . Anesthesiology93: 489—496
126.
Pogatzki E.M. , Niemeier J.S. , Sorkin L.S. , Brennan T.J. (2003) Spinal glutamate receptor antagonists differentiate primary and secondary mechanical hyperalgesia caused by incision . Pain105: 97—107
127.
Price D.D. , Mao J. , Frenk H. , Mayer D.J. (1994) The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man . Pain59: 165—174
128.
Price D.D. , Staud R. , Robinson M.E. , Mauderli A.P. , Cannon R. , Vierck C.J. (2002) Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients . Pain99: 49—59
129.
Pud D. , Eisenberg E. , Spitzer A. , Adler R. , Fried G. , Yarnitsky D. (1998) The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial . Pain75: 349—354
130.
Rabben T. , Skjelbred P. , Oye I. ( 1999) Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain . J Pharmacol Exp Ther289: 1060—1066
131.
Sandkuhler J. , Liu X. ( 1998) Induction of long-term potentiation at spinal synapses by noxious stimulation or nerve injury . Eur J Neurosci10: 2476—2480
132.
Sandkuhler J. , Benrath J. , Brechtel C. , Ruscheweyh R. , Heinke B. (2000) Synaptic mechanisms of hyperalgesia . Prog Brain Res129: 81—100
133.
Sang C.N. (2000) NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials . J Pain Symptom Manage19: S21-S25
134.
Sang C.N. , Booher S. , Gilron I. , Parada S. , Max M.B. (2002) Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials . Anesthesiology96: 1053—1061
135.
Schaible H.G. , Ebersberger A. , Von Banchet G.S. (2002) Mechanisms of pain in arthritis . Ann N Y Acad Sci966: 343—354
136.
Schmid R.L. , Sandler A.N. , Katz J. ( 1999) Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes . Pain82: 111—125
137.
Sindrup S.H. , Jensen T.S. (1999) Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action . Pain83: 389—400
138.
Sindrup S.H. , Jensen T.S. (2000) Pharmacologic treatment of pain in polyneuropathy . Neurology55: 915—920
139.
Skilling S.R. , Smullin D.H. , Beitz A.J. , Larson A.A. (1988) Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation . J Neurochem51: 127—132
140.
Smith D.J. , Perrotti J.M. , Mansell A.L. , Monroe P.J. (1985) Ketamine analgesia is not related to an opiate action in the periaqueductal gray region of the rat brain . Pain21: 253—265
141.
Smith D.J. , Bouchal R.L. , deSanctis C A. , Monroe P.J. , Amedro J.B. , Perrotti J.M. , Crisp T. (1987) Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro . Neuropharmacology26: 1253—1260
142.
Sorensen J. , Bengtsson A. , Backman E. , Henriksson K.G. , Bengtsson M. (1995) Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine . Scand J Rheumatol24: 360—365
143.
Sorensen J. , Bengtsson A. , Ahlner J. , Henriksson K.G. , Ekselius L. , Bengtsson M. (1997) Fibromyalgia — are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs . J Rheumatol24: 1615—1621
144.
Sorensen J. , Graven-Nielsen T. , Henriksson KG , Bengtsson M. , Arendt-Nielsen L. (1998) Hyperexcitability in fibromyalgia . J Rheumatol25: 152—155
145.
Staud R. , Vierck C.J. , Cannon R.L. , Mauderli A.P. , Price D.D. (2001) Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome . Pain91: 165—175
146.
Staud R. , Smitherman ML (2002) Peripheral and central sensitization in fibromyalgia: pathogenetic role . Curr Pain Headache Rep6: 259—266
147.
Staud R. , Price D.D. , Robinson M.E. , Mauderli A.P. , Vierck C.J. (2004) Maintenance of windup of second pain requires less frequent stimulation in fibromyalgia patients compared to normal controls . Pain110: 689—696
148.
Takahashi R.N. , Morato G.S. , Rae G.A. (1987) Effects of ketamine on nociception and gastrointestinal motility in mice are unaffected by naloxone . Gen Pharmacol18: 201—203
149.
Teoh H. , Malcangio M. , Bowery NG (1996) GABA, glutamate and substance P-like immunoreactivity release: effects of novel GABAB antagonists . Br J Pharmacol118: 1153—1160
150.
Thompson S.W. , King A.E. , Woolf C.J. (1990) Activity-dependent changes in rat ventral horn neurons in vitro: summation of prolonged afferent evoked postsynaptic depolarizations produce a d-2-amino-5-phosphonovaleric acid sensitive windup . Eur J Neurosci2: 638—649
151.
Thompson S.W. , Dray A. , Urban L. (1994) Injury-induced plasticity of spinal reflex activity: NK1 neurokinin receptor activation and enhanced A- and C-fiber mediated responses in the rat spinal cord in vitro . J Neurosci14: 3672—3687
152.
Tverskoy M. , Oz Y. , Isakson A. , Finger J. , Bradley E L, Jr, Kissin I (1994) Preemptive effect of fentanyl and ketamine on postoperative pain and wound hyperalgesia . Anesth Analg78: 205—209
153.
Urban L. , Thompson S.W. , Dray A. ( 1994) Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters . Trends Neurosci17: 432—438
154.
Ushida T. , Tani T. , Kanbara T. , Zinchuk V.S. , Kawasaki M. , Yamamoto H. (2002) Analgesic effects of ketamine ointment in patients with complex regional pain syndrome type 1 . Reg Anesth Pain Med27: 524—528
155.
Verne G.N. , Price D.D. (2002) Irritable bowel syndrome as a common precipitant of central sensitization . Curr Rheumatol Rep4: 322—328
156.
Verne G.N. , Robinson M.E. , Vase L. , Price D.D. (2003) Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients . Pain105: 223—230
157.
Warncke T. , Jorum E. , Stubhaug A. (1997a) Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action . Neurosci Lett227: 1—4
158.
Warncke T. , Stubhaug A. , Jorum E. (1997b) Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo . Pain72: 99—106
159.
Whitehead W.E. , Palsson O. , Jones K.R. (2002) Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?Gastroenterology122: 1140—1156
160.
Wiech K. , Kiefer RT , Topfner S. , Preissl H. , Braun C. , Unertl K. , Flor H. , Birbaumer N. (2004) A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain . Anesth Analg98: 408—14 , Table
161.
Willert R. , Woolf C. , Hobson A. , Delaney C. , Thompson D. , Aziz Q. ( 2004) The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-d-aspartate receptor . Gastroenterology126: 683—692
162.
Winters W.D. , Hance A.J. , Cadd G.G. , Quam D.D. , Benthuysen J.L. (1988) Ketamine- and morphine-induced analgesia and catalepsy. I. Tolerance, cross-tolerance, potentiation, residual morphine levels and naloxone action in the rat . J Pharmacol Exp Ther244: 51—57
163.
Wolfe F. , Smythe H.A. , Yunus M.B. , Bennett R.M. , Bombardier C. , Golden-berg D.L. , Tugwell P. , Campbell S.M. , Abeles M. , Clark P. , . (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee . Arthritis Rheum33: 160—172
164.
Wong C.S. , Lu C.C. , Cherng C.H. , Ho S.T. (1997) Pre-emptive analgesia with ketamine, morphine and epidural lidocaine prior to total knee replacement . Can J Anaesth44: 31—37
165.
Zahn P.K. , Pogatzki-Zahn EM , Brennan TJ (2005) Spinal administration of MK-801 and NBQX demonstrates NMDA-independent dorsal horn sensitization in incisional pain . Pain114: 499—510
166.
Zukin S.R. , Fitz-Syage M.L. , Nichtenhauser R. , Zukin RS (1983) Specific binding of [3H]phencyclidine in rat central nervous tissue: further characterization and technical considerations . Brain Res258: 277—284
